It is common for people to be carriers of at least one genetic condition. Carriers are usually healthy; however, they risk passing on a genetic condition to their children. Horizon carrier screening is a type of genetic test that allows you to determine your risk for passing an inherited genetic condition onto your child.
Most people do not know they are a carrier for an inherited genetic disease until they have a child with the condition. Everyone can be a carrier of a genetic condition regardless of ethnicity, family background, or family history.
Genetic carrier screening performed at a DNA testing center or genetics center can help you and your partner learn if you are likely to pass a genetic condition to your child, before or even during pregnancy. With Horizon genetic carrier screening, you screen for one or many genetic diseases in one simple test. Before undergoing carrier screening, it may be helpful to learn more about genetics and inheritance of diseases.
Using the latest technologies, including next-generation sequencing, Horizon screens for up to 274 genetic conditions, including commonly screened conditions such as cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and sickle cell anemia.
Advanced technology and unmatched support make Horizon unique among DNA screening tests. The test is easy to take. Results are presented clearly, directly, and can pave the way to critical action steps.
Comprehensive, actionable carrier screening.
All of us are carriers of at least one genetic condition. Most have no family history of the genetic condition they carry or understanding of how that condition could impact their child.
Carrier screening is a type of test that allows you to determine your risk for passing an inherited genetic condition onto your child. When performed before conceiving, genetic carrier screening provides you with actionable knowledge and the opportunity to pursue alternative reproductive options.
Carrier screening during pregnancy (prenatal carrier screening) can also have life-altering benefits: It can help couples decide on diagnostic testing, and if necessary, help them prepare emotionally, medically, and financially for a baby affected by a genetic condition.
cfDNA screening for skeletal, cardiac, and neurological disorders
Vistara identifes risk for single-gene disorders that may have otherwise gone undetected prenatally:
• Ultrasound fndings are not a reliable indicator
• Conditions are not detected with standard microarray analysis
• Family history is typically not a good indicator of risk
• Early identifcation of these conditions is clinically actionable.
VISTARA NIPT test screens non-invasively for
• Noonan syndrome
• Osteogenesis imperfecta
• Rett syndrome
• Achondroplasia
and other serious genetic conditions caused by single-gene mutations across 30 genes.
Conditions screened by VISTARA have a combined incidence of 1 in 600 – higher than that of Down syndrome.
All conditions screened meet at least one of the following criteria:
• Cause cognitive disability
• Require surgical or medical intervention
• Affect quality of life.
The single-gene disorders screened by Vistara are usually not inherited or related to family history
• Typically caused by new, or “de novo,” genetic changes (variants)
• May occur more frequently as the age of the father increases
• Are not related to the age of the mother
• Are autosomal or X-linked dominant – if the variant is present, the child is expected to be affected by the condition and experience related symptoms.
The PanoramaTM prenatal screen is a DNA screening test. Panorama provides you with information about the chance that your baby has certain genetic conditions.
Panorama is the only NIPT that can tell the difference between the mother’s and the baby’s DNA, which results in fewer false positives and fewer false negatives.
Femina MC was created with women in mind. We provide a wide range of gynaecological services to help you out with any feminine health issues you might have, including:
Gabinet Femina MC feruje badanie USG, pozwalające poznać płeć płodu.
Właśnie w tym celu robi się badanie USG w 3D/4D. Dzięki bardzo dobremu aparatowi USG, jesteśmy w stanie na 100 proc. potwierdzić płeć płodu już od 16. tygodnia ciąży!
USG 3D/4D, czyli inaczej badanie Gender Scan, to nieinwazyjny test prenatalny USG, który pozwala wykryć płeć już po 10 tygodniu ciąży. Dzięki technologii 3/4D możemy nie tylko zobaczyć płeć, ale też możemy pokazać rączki i nóżki, a nawet rysy twarzy! Zestaw bardzo czułe USG plus specjalne oprogramowanie pozwala zrobić trójwymiarowy model twarzyczki dziecka. W ten sposób pomagamy nawiązać więź uczuciową z nienarodzonym dzieckiem. Badanie pomaga również ocenić anatomię płodu – czyli jego budowę.
Koszt badania wynosi 160 euro, jeśli wynik jest nagrywany na pendrive, koszt wynosi 170 euro.
Appointments are mandatory.
Please make an appointment by phone, preferably one week in advance. In case of urgent matters, we adapt to the needs of our patients.
Patients are enrolled every half hour. There is a comfortable waiting room at their disposal, equipped with armchairs and a sofa. We offer our patients coffee and cold drinks, as well as women's magazines.
We provide the opportunity of using our bathroom and refreshing intimate wipes to the ladies who come to us straight from work.
The waiting room opens a quarter of an hour before the office opening time.
We choose the method of contraception so it goes with your lifestyle, age, sexual activity and health conditions. We will help every woman find the perfect solution for her!
We help future mothers in their efforts to have a baby, we fight for endangered pregnancies and perform imaging tests that monitor the development of the fetus.
These tests are performed BEFORE there are any health problems. Their task is to detect various changes early enough that they can be quickly and successfully treated.
Appointments by phone: +353 86 411 0003
Appointments by email: feminamcltd@gmail.com
Copyright Femina MC 2023 All rights reserved.
Site design: